BBA
ACHV icon

BLB&B Advisors’s Achieve Life Sciences ACHV Stock Holding History

BLB&B Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-144
Closed -$37K – 302
2018
Q1 		$37K Buy
+144
New +$41.2K ﹤0.01% 307
2014
Q3 		– Sell
-7
Closed -$54K – 284
2014
Q2 		$54K Sell
7
-7
-50% -$86K 0.01% 283
2014
Q1 		$369K Buy
14
+4
+40% +$98.3K 0.08% 205
2013
Q4 		$183K Buy
10
+1
+11% +$17.5K 0.04% 242
2013
Q3 		$182K Buy
+9
New +$186K 0.05% 232

Other funds holding ACHV

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

BLB&B Advisors's ACHV Position: Q2 2018 in Review

BLB&B Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2018, closing a stake of 144 shares — an estimated $37K sold.

BLB&B Advisors first reported a position in ACHV in Q3 2013 and held it in 5 quarters. The position peaked at $369K in Q1 2014. 15 funds tracked by Wall St. Rank hold ACHV as of Q2 2018.

  • BLB&B Advisors reported no remaining Achieve Life Sciences position as of Q2 2018 after selling out during the quarter.
  • BLB&B Advisors sold 144 Achieve Life Sciences shares in Q2 2018, an estimated $37K.
  • BLB&B Advisors first reported a position in Achieve Life Sciences in Q3 2013 and held it in 5 quarters.
  • BLB&B Advisors's Achieve Life Sciences position peaked at $369K in Q1 2014.
  • 15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2018.

Based on BLB&B Advisors's 13F filing for Q2 2018, filed 11 Jul 2018.